BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, November 27, 2024
Home
»
Topics
»
Disease categories and therapies
» Ocular
Ocular
RSS
Alcon discloses new antiglaucoma agents in patent literature
Jan. 2, 1998
No Comments
Medarex's secondary cataract product enters phase III
Dec. 19, 1997
No Comments
Pharmacyclics grants Alcon rights to Lu-Tex
Dec. 19, 1997
No Comments
InSite Vision brings its once-daily glaucoma treatment to clinical trials
Dec. 8, 1997
No Comments
Alcon compounds with dual antioxidant/cysteine prodrug properties
Dec. 8, 1997
No Comments
Spotlight on carbonic anhydrase inhibitors for glaucoma
Nov. 25, 1997
No Comments
KeraVision Ring evaluated in extended phase III trial
Nov. 21, 1997
No Comments
Promising phase III results reported for KeraVision ring
Nov. 4, 1997
No Comments
German launch for Xalatan
Oct. 23, 1997
No Comments
Patient recruitment for verteporfin phase III trials exceeds goals
Sep. 30, 1997
No Comments
Previous
1
2
…
367
368
369
370
371
372
373
374
375
…
381
382
Next
RSS